ROR-gamma T inhibitors (Boehringer Ingelheim Pharmaceuticals)

N/A

Report date: 2025/01/26 17:10:15
NME

Base Information

Drug NameROR-gamma T inhibitors (Boehringer Ingelheim Pharmaceuticals)
Drug Alias NameBIX-119
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor ROR-gamma inverse agonists
TargetsNuclear receptor ROR-gamma
Therapy Area/IndicationsInflammationAutoimmune DiseasesSpondylarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim Corp
China Registration ClassN/A

Develop Information

Active CompaniesBoehringer Ingelheim Corp
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune DiseasesSpondylarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A